The prevention of bloodstream infections (BSI) is typically focused on central venous catheters (CVCs).
Arterial catheters are not risk free. Here is a paper recently published in the Journal of Hospital Infection on the risk of catheter related BSI.
The Of 834 arterial catheters studied (3273 catheter-days), 109 (13%) were colonized and 11 caused bacteremia (1.3%, 3.4 per 1000 catheter-days). The majority of catheter-related BSIs were acquired extraluminally from skin of the insertion site (63%). The risk of arterial catheter-related BSI was comparable with that for short-term non-cuffed central venous catheters (2.7%, 5.9 per 1000 CVC-days).
As the most common route of infection is extraluminal, the authors make a persuasive argument for the employment of proven risk reduction interventions used for CVCs, such as chlorhexidine for cutaneous antisepsis and chlorhexidine-impregnated dressings.
I will be at the ID WEEK 2013 in San Francisco for the remainder of the week.
I will post updates from the conference on this blog.
Arterial catheters are not risk free. Here is a paper recently published in the Journal of Hospital Infection on the risk of catheter related BSI.
The Of 834 arterial catheters studied (3273 catheter-days), 109 (13%) were colonized and 11 caused bacteremia (1.3%, 3.4 per 1000 catheter-days). The majority of catheter-related BSIs were acquired extraluminally from skin of the insertion site (63%). The risk of arterial catheter-related BSI was comparable with that for short-term non-cuffed central venous catheters (2.7%, 5.9 per 1000 CVC-days).
As the most common route of infection is extraluminal, the authors make a persuasive argument for the employment of proven risk reduction interventions used for CVCs, such as chlorhexidine for cutaneous antisepsis and chlorhexidine-impregnated dressings.
I will be at the ID WEEK 2013 in San Francisco for the remainder of the week.
I will post updates from the conference on this blog.